Furthermore, Mu et al. identified that the expression of CDH13mRNA in CML patients is lower than in healthy subjects, showing a negative correlation with the BCR-ABL1 fusion gene that may contribute to CML development [28]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.